daunorubicin has been researched along with n-(4-glucuronyl-3-nitrobenzyloxycarbonyl)doxorubicin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrianomenjanahary, S; Bosslet, K; Czech, J; Dong, X; Florent, JC; Gaudel, G; Gerken, M; Gesson, JP; Jacquesy, JC; Koch, M; Michel, S; Mitaku, S; Mondon, M; Monneret, C; Renoux, B; Straub, R; Tillequin, F | 1 |
1 other study(ies) available for daunorubicin and n-(4-glucuronyl-3-nitrobenzyloxycarbonyl)doxorubicin
Article | Year |
---|---|
Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Carcinoembryonic Antigen; Cell Division; Daunorubicin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Stability; Escherichia coli; Glucuronates; Glucuronidase; Humans; Hydrolysis; Immunoglobulin Fab Fragments; Kinetics; Leukemia L1210; Mice; Prodrugs; Rats; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |